FDA OKs stem cell trial
California-based biotech company Geron Corp. announced today (Jan. 23) that it has received clearance from the U.S. Food and Drug Administration to begin trials for the world's first clinical study on human embryonic stem cell-based therapy. linkurl:Geron;https://www.geron.com/ plans to initiate a Phase I multicenter clinical trial in up to 10 patients paralyzed due to spinal cord injury. Its treatment -- currently referred to as "GRNOPC1" -- uses embryonic stem cells coaxed to become nerve cell
Written byElie Dolgin
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
**__Related stories:__***linkurl:Stem cell trial nearly a go?;https://www.the-scientist.com/article/blog/55096/
[17th October 2008]*linkurl:First embryonic stem cell trial stalled;https://www.the-scientist.com/blog/display/54647/
[15th May 2008]*linkurl:FDA mulls embryonic stem cell therapy;https://www.the-scientist.com/blog/display/54544/
[11th April 2008]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Meet the Author
- This person does not yet have a bio.View Full Profile
